Physician
Lee, Han
Lee, Han was paid $582K by Medicaid between Jan 2018 and Dec 2024, across 20 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 28% of everything it billed.
33Billing provider infoLEE, HAN
FLUSHING, NY 11354
FLUSHING, NY 11354
33aNPI1235168964assigned 07/03/2006
33bProvider typePain Medicine Physician
28Total paid$582K
24GClaims33,048
24DCodes billed20
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pain Medicine Physician providers in New York
Rank by total paid#6 of 47
Median peer was paid$12K
This provider vs. median49×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,231 | $36K | |
| 2019 | 4,116 | $63K | |
| 2020 | 3,841 | $46K | |
| 2021 | 4,855 | $77K | |
| 2022 | 5,319 | $105K | |
| 2023 | 5,531 | $111K | |
| 2024incomplete | 6,155 | $145K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 5,911 | 4,703 | $162K |
| 20611 | 22% | 9,040 | 4,431 | $125K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 14% | 4,998 | 3,983 | $83K |
| J7325 | Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg | 12% | 2,431 | 1,280 | $68K |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 6.8% | 872 | 405 | $40K |
| 76881 | 4.5% | 1,756 | 1,648 | $26K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.0% | 367 | 366 | $18K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 3.0% | 3,832 | 3,176 | $18K |
| J7321 | Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 2.8% | 1,288 | 550 | $16K |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | 1.4% | 1,347 | 569 | $8K |
| J7323 | Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 1.0% | 264 | 119 | $6K |
| 62323 | <1% | 91 | 88 | $4K |
8 more codes
| 76942 | <1% | 251 | $4K | |
| 64483 | <1% | 85 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 53 | $2K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 194 | $901.94 |
| 64484 | <1% | 46 | $548.07 | |
| 20550 | <1% | 13 | $175.30 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 13 | $21.68 |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 0% | 196 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.